YU-TSUNG HUANGHsiao C.-H.Liao C.-H.CHUNG-WEI LEEPO-REN HSUEH2021-05-182021-05-1820080095-1137https://scholars.lib.ntu.edu.tw/handle/123456789/561206We describe the development of nonsusceptibility to daptomycin and vancomycin during treatment for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia associated with infective endocarditis and probable septic thrombophlebitis in a uremic patient. MRSA bacteremia persisted during glycopeptide and subsequent daptomycin treatment but cleared after 5 days' treatment with linezolid and fusidic acid. Copyright ? 2008, American Society for Microbiology. All Rights Reserved.[SDGs]SDG3daptomycin; fusidic acid; linezolid; teicoplanin; vancomycin; aged; anamnesis; antibiotic resistance; article; bacteremia; bacterial endocarditis; bacterial strain; blood culture; blood vessel graft; Candida albicans; case report; computer assisted tomography; disease association; drug eruption; drug substitution; drug withdrawal; human; laboratory test; male; methicillin resistant Staphylococcus aureus; multiple organ failure; nonhuman; physical examination; priority journal; septic shock; Taiwan; thrombophlebitis; transthoracic echocardiography; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Taiwan; Vancomycin; methicillin resistant Staphylococcus aureusjournal article10.1128/JCM.01844-07181997932-s2.0-40749132171